Drug
Darusentan clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Gilead Sciences (5) · K.Lance Gould (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses darusentan is read from its arms, and is right about nine times in ten.
Testing it · 6
- Darusentan Effect on PET Uptake HeterogeneityCompletedPhase 2K.Lance GouldNCT00738049Written as darusentan 100 mg
- DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant HypertensionCompletedPhase 3Gilead SciencesNCT00330369Written as Darusentan
- DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant HypertensionCompletedPhase 3Gilead SciencesNCT00389779Written as Darusentan
- DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant HypertensionTerminatedPhase 3Gilead SciencesNCT00353574Written as Darusentan
- DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant HypertensionTerminatedPhase 3Gilead SciencesNCT00389675Written as Darusentan
- A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering DrugsCompletedPhase 2Gilead SciencesNCT00364026Written as darusentan
Codes
What other systems call darusentan · ClinicalTrials.gg INT004011
- MeSH (NLM) C107831darusentanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 33JD57L6RWDARUSENTANConfirmed FDA, NLM, Wikidata
- Wikidata Q5225810darusentanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75991DarusentanOne source FDA
- DrugBank DB04883One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C107831 | darusentan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 33JD57L6RW | DARUSENTAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5225810 | darusentan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75991 | Darusentan | One source FDA |
| DrugBank | DB04883 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.